Regular biography
Matthew Fuchter is Professor of Chemistry at the University of Oxford and the Sydney Bailey Fellow in Chemistry at St Peter’s College Oxford. His research focuses on the development of photoswitchable molecules and chiral materials for optoelectronic applications, with applications spanning photopharmacology, energy storage, and advanced functional materials. His group explores the synthesis and application of molecular photoswitches, particularly heteroaromatic azo compounds, and investigates chiral conjugated systems for next-generation technologies. Fuchter also engages in drug discovery science, developing small molecule inhibitors for therapeutic applications. He is an inventor of two drugs undergoing clinical trials for cancer therapy and a founder of NK:IO Ltd, an immune-oncology spinout company.
Scholar-generated biography
Matthew J. Fuchter's research focuses on the development and application of chiral materials for advanced optoelectronic and biomedical technologies. His work explores the interaction of chiral light with chiral molecules, particularly in the context of circularly polarized light detection and emission. Fuchter has investigated chiral organic semiconductors, light-emitting polymers, and small-molecule dopants to achieve high dissymmetry factors in electroluminescence. His research also extends to photoswitches, photopharmacology, and hydrogenation catalysis, emphasizing the design of materials with tunable optical and chemical properties. These studies highlight the potential of chiral materials in next-generation optoelectronics and therapeutic applications.